Entering text into the input field will update the search result below

Atossa Genetics reports FY'14 results

  • Atossa Genetics (NASDAQ:ATOS): FY'14 EPS of -$0.61 vs. -$0.70 in FY'13
  • Revenue of $0.52M (-17.5% Y/Y).
  • Press Release

Recommended For You

More Trending News

About ATOS Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
ATOS--
Atossa Therapeutics, Inc.